The Asia-Pacific (APAC) Injectable Drug Delivery Market is undergoing a profound transformation. This market is projected to reach USD 282.22 billion by 2031 from USD 176.96 billion in 2026, growing at a CAGR of 9.8% during the forecast period. This growth is fueled by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside an escalating burden of chronic diseases across the region.
As demand rises for patient-centric delivery and self-administration, industry leaders are advancing formulation science and scalable sterile manufacturing to support oncology, immunology, and diabetes therapies.
Spotlight on the Industry’s Top Injectable Drug Delivery Companies
The following 19 industry leaders stand out for their technical innovations, strategic focus, and pivotal roles in clinical diagnostics and research across the APAC region.
1. Terumo Corporation
A Japanese medical giant, Terumo is a leader in advanced needle technology and prefillable syringes. Their focus on reducing injection pain and improving safety through R&D makes them a preferred partner for chronic disease management.
2. Nipro
Nipro excels in high-volume manufacturing of glass and plastic syringes. Their global distribution network ensures that high-quality, cost-effective injectable solutions are accessible throughout emerging APAC markets.
3. Hindustan Syringes & Medical Devices Ltd (HMD)
As one of the world’s largest syringe manufacturers, HMD is critical to the region’s immunization programs. Their focus on auto-disable (AD) syringes helps prevent the reuse of medical devices, enhancing public health safety.
4. B. Braun SE
B. Braun provides comprehensive infusion therapy and pain management solutions. Their systems are known for balancing high technical standards with intuitive designs, supporting both hospital and decentralized clinical settings.
5. Gerresheimer AG
Gerresheimer is a specialist in pharmaceutical glass and plastic containment. Their expertise in specialty vials and syringes is vital for the stability of sensitive biologics and high-value injectable drugs.
6. Schott Pharma
Schott Pharma is recognized for its high-performance containment solutions. Leveraging advanced materials science, they deliver vials and syringes that meet the stringent regulatory requirements of the modern pharmaceutical industry.
7. West Pharmaceutical Services, Inc.
Specializing in containment and delivery systems, West provides essential components like stoppers and seals. Their commitment to innovation supports the delivery of complex injectable therapies with high reliability.
8. Stevanato Group
Stevanato Group offers integrated drug delivery solutions, from glass containers to contract manufacturing. Their modular approach allows pharmaceutical companies to scale production efficiently while maintaining strict quality controls.
9. Ypsomed AG
A leader in self-injection systems, Ypsomed specializes in pen and autoinjector platforms. Their focus on digital health and smart connected devices empowers patients to manage chronic conditions like diabetes at home.
10. Pfizer Inc.
Pfizer commands a massive presence in the region through its robust pipeline of injectable biologics and vaccines. Their investment in regional manufacturing capacity ensures readiness for evolving clinical demands.
11. Sanofi
Sanofi is a major player in the diabetes and immunology sectors. Their innovative delivery platforms, particularly for insulin, are tailored to enhance patient compliance and ease of use in diverse clinical environments.
12. F. Hoffmann-La Roche Ltd
Roche focuses on precision medicine and advanced diagnostics. Their injectable solutions are often paired with diagnostic tools to provide integrated care for oncology and autoimmune disorders.
13. Novo Nordisk A/S
Specializing in metabolic health, Novo Nordisk drives innovation in injectable therapies for diabetes and obesity. Their focus on smart-pen technology is a key driver for the regional adoption of digital health platforms.
14. Novartis AG
Novartis leverages expertise in biosimilars and cell therapies. Their strategic investments in the APAC region focus on delivering high-efficacy injectables that address the growing burden of specialty diseases.
15. Takeda Pharmaceutical Company Limited
As Japan’s largest pharmaceutical company, Takeda is a regional powerhouse. Their portfolio of injectable therapies for rare diseases and gastroenterology is defined by rigorous clinical validation and a patient-first philosophy.
16. AstraZeneca
AstraZeneca stands out for its diverse portfolio of injectable treatments in oncology and cardiovascular health. Their focus on sustainable healthcare delivery aligns with the regional shift toward efficient, high-value diagnostics.
17. Sun Pharmaceutical Industries Ltd.
Sun Pharma is a leading provider of affordable specialty injectables. Their strength lies in making complex delivery systems accessible to a broad user base across India and Southeast Asia.
18. Cipla
Cipla is recognized for its focus on respiratory and infectious disease treatments. Their injectable portfolio balances affordability with high analytical accuracy, serving both urban hospitals and rural clinics.
19. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s excels in the development of complex generics and biosimilar injectables. Their commitment to robust quality control protocols and digital connectivity supports long-term value for healthcare providers.
Conclusion: Unlock the Full Injectable Drug Delivery Market Intelligence
The APAC market’s future is shaped by technological convergence and the regional adoption of home-based care. To explore in-depth trends and actionable recommendations for sustainable growth, access the full APAC Injectable Drug Delivery Market by Product, Site of Administration, Formulation Packaging, Usage Pattern – Forecast to 2031 report now.